30050BAH4

Evolent Health, Inc.

Could not find a ticker for this position, may be a filing error

A healthcare services company that helps health plans, providers, and hospitals manage complex, high-cost conditions like cancer, heart disease, and musculoskeletal care. It uses its Identifi technology platform and clinical programs to help organizations move from simply billing per visit to "value-based care" that rewards better outcomes. Evolent was founded in 2011 as a joint venture between UPMC and The Advisory Board Company, based in Arlington, Virginia. Its name blends "evolution" and "benevolent," chosen to signal a kinder, transforming approach to healthcare.

CONVERTIBLEUnderlying: EVHCUSIP: 30050BAH4HealthcareUS1 derivative reporter

3.5% Convertible Senior Notes due 2029

Ownership Activity Financials Filings

Insiders

Ranked by how much each holding moved in the last 5 years

Insider

Williams Frank JDirector · 59 transactions

885.9K+27.7%

as of Jun 2023

Granted 1.93M · Sold 1.41M

Blackley SethChief Executive Officer, Director · 45 transactions

837.0K+308.6%

Granted 2.54M · Bought 55.2K · Sold 833.9K

McCarthy Daniel JosephPRESIDENT · 30 transactions

423.0K—

Granted 437.8K · Bought 11.0K · Sold 46.2K

Johnson John PaulChief Financial Officer · 22 transactions

309.2K+125.9%

as of Jul 2025

Granted 390.4K · Sold 63.1K

Weinberg JonathanGeneral Counsel · 32 transactions

244.5K+144.4%

Granted 320.4K · Sold 84.5K

Tutewohl SteveChief Operating Officer · 17 transactions

136.3K+19.5%

as of Jul 2023

Granted 72.0K · Sold 28.9K

Rafferty Emily AnnChief Operating Officer · 9 transactions

132.6K—

as of Mar 2025

Granted 89.3K · Sold 16.8K

Grua Peter JDirector · 6 transactions

123.7K—

Granted 81.4K · Bought 11.0K

Jelinek Richard MDirector · 6 transactions

107.5K—

Granted 75.8K · Bought 30.0K

Keck KimDirector · 6 transactions

102.6K+862.4%

Granted 81.4K · Bought 10.5K

Springstubb Brendan BDirector · 6 transactions

99.9K—

Granted 69.9K · Bought 30.0K

Barbarosh Craig A.Director · 6 transactions

95.0K+716.8%

Granted 81.4K · Bought 2.0K

Glass Russell MonroeDirector · 5 transactions

83.4K—

Granted 71.9K · Bought 5.4K

Ajayi ToyinDirector · 4 transactions

75.2K—

Granted 75.2K

Scott CherylDirector · 6 transactions

73.5K+51.1%

as of Jun 2025

Granted 40.3K · Sold 5.5K

Holder DianeDirector · 5 transactions

70.6K+14.7%

as of Mar 2025

Granted 18.3K · Bought 2.7K · Sold 12.0K

Farner DavidDirector · 1 transaction

67.1K+9%

as of Jun 2022

Granted 5.6K

Shams AammaadChief Accounting Officer · 18 transactions

66.8K+345.6%

Granted 80.5K

Smith Jill D.Director · 2 transactions

64.2K—

Granted 64.2K

Guertin Shawn MDirector · 2 transactions

63.1K—

Granted 63.1K

Duffy Mary BridgetDirector · 5 transactions

48.0K-8.4%

as of Jun 2024

Granted 18.3K · Sold 13.1K

Sotunde TundeDirector · 3 transactions

14.0K—

as of Jun 2023

Granted 14.0K

Ramos MarioChief Financial Officer · 1 transaction

0—

Granted 587.5K

Insider	Stake change	Holds now	Granted / vested	Bought	Sold
Williams Frank JDirector · 59 transactions	+27.7%	885.9Kas of Jun 2023	1.93M	—	1.41M
Blackley SethChief Executive Officer, Director · 45 transactions	+308.6%	837.0K	2.54M	55.2K	833.9K
McCarthy Daniel JosephPRESIDENT · 30 transactions	—	423.0K	437.8K	11.0K	46.2K
Johnson John PaulChief Financial Officer · 22 transactions	+125.9%	309.2Kas of Jul 2025	390.4K	—	63.1K
Weinberg JonathanGeneral Counsel · 32 transactions	+144.4%	244.5K	320.4K	—	84.5K
Tutewohl SteveChief Operating Officer · 17 transactions	+19.5%	136.3Kas of Jul 2023	72.0K	—	28.9K
Rafferty Emily AnnChief Operating Officer · 9 transactions	—	132.6Kas of Mar 2025	89.3K	—	16.8K
Grua Peter JDirector · 6 transactions	—	123.7K	81.4K	11.0K	—
Jelinek Richard MDirector · 6 transactions	—	107.5K	75.8K	30.0K	—
Keck KimDirector · 6 transactions	+862.4%	102.6K	81.4K	10.5K	—
Springstubb Brendan BDirector · 6 transactions	—	99.9K	69.9K	30.0K	—
Barbarosh Craig A.Director · 6 transactions	+716.8%	95.0K	81.4K	2.0K	—
Glass Russell MonroeDirector · 5 transactions	—	83.4K	71.9K	5.4K	—
Ajayi ToyinDirector · 4 transactions	—	75.2K	75.2K	—	—
Scott CherylDirector · 6 transactions	+51.1%	73.5Kas of Jun 2025	40.3K	—	5.5K
Holder DianeDirector · 5 transactions	+14.7%	70.6Kas of Mar 2025	18.3K	2.7K	12.0K
Farner DavidDirector · 1 transaction	+9%	67.1Kas of Jun 2022	5.6K	—	—
Shams AammaadChief Accounting Officer · 18 transactions	+345.6%	66.8K	80.5K	—	—
Smith Jill D.Director · 2 transactions	—	64.2K	64.2K	—	—
Guertin Shawn MDirector · 2 transactions	—	63.1K	63.1K	—	—
Duffy Mary BridgetDirector · 5 transactions	-8.4%	48.0Kas of Jun 2024	18.3K	—	13.1K
Sotunde TundeDirector · 3 transactions	—	14.0Kas of Jun 2023	14.0K	—	—
Ramos MarioChief Financial Officer · 1 transaction	—	0	587.5K	—	—

Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.